Difamilast

Generic Name
Difamilast
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C23H24F2N2O5
CAS Number
937782-05-3
Unique Ingredient Identifier
T3U32GLJ0F
Background

Difamilast is under investigation in clinical trial NCT01702181 (A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis).

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)

Phase 3
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Placebo
Drug: Difamilast
First Posted Date
2022-11-08
Last Posted Date
2024-08-15
Lead Sponsor
Acrotech Biopharma Inc.
Target Recruit Count
153
Registration Number
NCT05608343
Locations
🇺🇸

Nona Pediatrics, Orlando, Florida, United States

🇺🇸

Tory Sullivan, MD PA, North Miami Beach, Florida, United States

🇺🇸

Avant Research Associates, LLC, Crowley, Louisiana, United States

and more 35 locations

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

Phase 3
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Difamilast
First Posted Date
2022-10-07
Last Posted Date
2024-08-09
Lead Sponsor
Acrotech Biopharma Inc.
Target Recruit Count
542
Registration Number
NCT05571943
Locations
🇺🇸

Qualmedica Research, LLC, Bowling Green, Kentucky, United States

🇺🇸

Antelope Valley Clinical Trials, Lancaster, California, United States

🇺🇸

Dermatology Research Associates, Los Angeles, California, United States

and more 56 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy